✦ LIBER ✦

Inequalities in oncology care: Economic consequences of high cost drugs

✍ Scribed by Maartje G.H. Niezen; Elly A. Stolk; Adri Steenhoek; Carin A. Uyl-De Groot

Book ID: 116429120
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 177 KB
Volume: 42
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2006.07.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PHP17 Characteristics of High Cost Ambul

PHP17 Characteristics of High Cost Ambulatory Drugs in French Health Care System

✍ I. Gridchyna; M. Aulois-Griot; C. Pulon; C. Maurain; B. Bégaud 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

The distribution problem in economic eva

The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes

✍ Cam Donaldson; Stephen Birch; Amiram Gafni 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 2 views

To date, a common view in the health economics literature is that the applicability of cost-benefit analysis (CBA) is limited, due to the distribution problem which underlies its main method of valuation (e.g. willingness to pay). One view is that cost effectiveness analysis (CEA) overcomes these pr

Adverse-drug-event rates for high-cost a

Adverse-drug-event rates for high-cost and high-use drugs in the intensive care unit

✍ Kane-Gill, S. 📂 Article 📅 2006 🏛 American Society of Health-System Pharmacists 🌐 English ⚖ 124 KB